Hemi Health Secures €4M for Migraine Care
What happened
Hemi Health, a female-led healthtech startup based in Denmark, has secured €4 million in funding. The company will use the capital to expand its migraine and concussion care platform internationally. The investment highlights a growing focus on specialized, technology-enabled women's health solutions within the venture capital community.
Why it matters
- The €4 million seed funding round was led by Denmark's Export and Investment Fund (EIFO) and Swiss Health Ventures, with participation from existing investors Sondo Capital, Alliance Venture Capital, and Crowberry Capital. - Founded in 2023, Hemi Health has already provided care to over 1,000 individuals suffering from migraines, headaches, and concussions through its physical clinics in Denmark and its digital platform. - The company's international expansion will begin with the Netherlands, where it plans to establish a clinic and align with insurance-driven healthcare systems. - A significant portion of the new capital will be used to further develop Hemi Health's proprietary digital platform, with a focus on leveraging AI to create structured and measurable care programs. - The company was co-founded by Benedicte Grytte Dahl, Anna Løfqvist, Sune K-Holm Nielsen, and Mathias Iversen. Løfqvist has stated that her personal experience with migraines was a driving force behind creating a more streamlined and effective care pathway. - Hemi Health's platform combines a digital app for video consultations and symptom tracking with physical clinics, offering a multidisciplinary treatment model for complex neurological conditions, including whiplash. - The investment in Hemi Health aligns with a positive trend in women's health technology; while overall venture funding in health tech saw a decline, investment in women's health-focused companies has shown growth. - The global market for women's health technology is projected to grow to US$60 billion by 2027, yet the sector currently receives a disproportionately small percentage of total health tech funding.
Key numbers
- Hemi Health, a female-led healthtech startup based in Denmark, has secured €4 million in funding.
- - The €4 million seed funding round was led by Denmark's Export and Investment Fund (EIFO) and Swiss Health Ventures, with participation from existing investors Sondo Capital, Alliance Venture Capital, and Crowberry Capital.
- Founded in 2023, Hemi Health has already provided care to over 1,000 individuals suffering from migraines, headaches, and concussions through its physical clinics in Denmark and its digital platform.
- The global market for women's health technology is projected to grow to US$60 billion by 2027, yet the sector currently receives a disproportionately small percentage of total health tech funding.
What happens next
- The company's international expansion will begin with the Netherlands, where it plans to establish a clinic and align with insurance-driven healthcare systems.
- A significant portion of the new capital will be used to further develop Hemi Health's proprietary digital platform, with a focus on leveraging AI to create structured and measurable care programs.
- The company will use the capital to expand its migraine and concussion care platform internationally.
Quick answers
What happened in Hemi Health Secures €4M for Migraine Care?
Hemi Health, a female-led healthtech startup based in Denmark, has secured €4 million in funding. The company will use the capital to expand its migraine and concussion care platform internationally. The investment highlights a growing focus on specialized, technology-enabled women's health solutions within the venture capital community.
Why does Hemi Health Secures €4M for Migraine Care matter?
The €4 million seed funding round was led by Denmark's Export and Investment Fund (EIFO) and Swiss Health Ventures, with participation from existing investors Sondo Capital, Alliance Venture Capital, and Crowberry Capital. Founded in 2023, Hemi Health has already provided care to over 1,000 individuals suffering from migraines, headaches, and concussions through its physical clinics in Denmark and its digital platform. The company's international expansion will begin with the Netherlands, where it plans to establish a clinic and align with insurance-driven healthcare systems. A significant portion of the new capital will be used to further develop Hemi Health's proprietary digital platform, with a focus on leveraging AI to create structured and measurable care programs. The company was co-founded by Benedicte Grytte Dahl, Anna Løfqvist, Sune K-Holm Nielsen, and Mathias Iversen. Løfqvist has stated that her personal experience with migraines was a driving force behind creating a more streamlined and effective care pathway. Hemi Health's platform combines a digital app for video consultations and symptom tracking with physical clinics, offering a multidisciplinary treatment model for complex neurological conditions, including whiplash. The investment in Hemi Health aligns with a positive trend in women's health technology; while overall venture funding in health tech saw a decline, investment in women's health-focused companies has shown growth. The global market for women's health technology is projected to grow to US$60 billion by 2027, yet the sector currently receives a disproportionately small percentage of total health tech funding.
